Objective To assess the economic consequences of labour induction with Foley catheter compared to prostaglandin E 2 gel.Design Economic evaluation alongside a randomised controlled trial.Setting Obstetric departments of one university and 11 teaching hospitals in the Netherlands.Population Women scheduled for labour induction with a singleton pregnancy in cephalic presentation at term, intact membranes and an unfavourable cervix; and without previous caesarean section.Methods Cost-effectiveness analysis from a hospital perspective.Main outcome measures We estimated direct medical costs associated with healthcare utilisation from randomisation to 6 weeks postpartum. For caesarean section rate, and maternal and neonatal morbidity we calculated the incremental costeffectiveness ratios, which represent the costs to prevent one of these adverse outcomes.Results Mean costs per woman in the Foley catheter group (n = 411) and in the prostaglandin E 2 gel group (n = 408), were €3297 versus €3075, respectively, with an average difference of €222 (95% confidence interval À€157 to €633). In the Foley catheter group we observed higher costs due to longer labour ward occupation and less cost related to induction material and neonatal admissions. Foley catheter induction showed a comparable caesarean section rate compared with prostaglandin induction, therefore the incremental cost-effectiveness ratio was not informative. Foley induction resulted in fewer neonatal admissions (incremental cost-effectiveness ratio €2708) and asphyxia/postpartum haemorrhage (incremental cost-effectiveness ratios €5257) compared with prostaglandin induction.Conclusions Foley catheter and prostaglandin E 2 labour induction generate comparable costs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.